Valink Therapeutics

Valink Therapeutics: Discovering bispecific antibody drug-conjugates (BsADC) against cancer. Headquartered in Boston, MA, United States. Current operating status: active.

Oomira checked this YC company record against source evidence and keeps the current facts, observed dates, and provenance visible before the interactive app loads.

Summary

Discovering bispecific antibody drug-conjugates (BsADC) against cancer

2026-06-12 · 1 source

Description

Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications...

2026-06-12 · 1 source

Website

https://www.valinktx.com/

2026-06-12 · 2 sources

Hiring

no

2026-06-13 · 1 source

Headquarters

Boston, MA, United States

2026-06-13 · 1 source

Operating status

active

2026-06-12 · 1 source

Industry

Healthcare

2026-06-13 · 1 source

Open the full YC audit or continue into the interactive frozen world below.